Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Description

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Conditions

Acute Lymphoblastic Leukemia, Pediatric

Talk to us

Study Overview

On this page

Study Details

Study overview

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Condition
Acute Lymphoblastic Leukemia, Pediatric
Intervention / Treatment

-

Contacts and Locations

Buffalo

Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States, 14263

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  • * Parent has primary medication responsibility.
  • * Pediatric patient aged 3-9 years
  • * Child on therapy that includes home-based oral anti-cancer medication taken at home, such as 6-MP.
  • * Parent has verbal English or Spanish fluency.
  • * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
  • * Parent of a child who is not diagnosed nor being treated for any type of acute lymphoblastic leukemia (ALL) at a study site.
  • * Parent does not have primary medication responsibility.
  • * Pediatric patient aged 3-9 years
  • * Pediatric patient is not on therapy that includes oral anti-cancer medication (e.g., 6-MP).
  • * Parent does not have verbal English or Spanish fluency.
  • * Parent is unwilling or unable to follow protocol requirements

Ages Eligible for Study

3 Years to 9 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Roswell Park Cancer Institute,

Elizabeth Bouchard, PhD, PRINCIPAL_INVESTIGATOR, Roswell Park Comprehensive Cancer Center

Study Record Dates

2027-10-01